Shandong Xinhua Pharmaceutical Company Limited (XIN) — Strategic Asset Allocation Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Strategic Asset Allocation Index of 84.9% as of September 2023. Strategic assets (PP&E of €3.99 Billion plus long-term investments of €-) total €3.99 Billion, measured against net assets of €4.70 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Shandong Xinhua Pharmaceutical Company Limited Strategic Asset Allocation Index (2013–2022)
This chart shows how Shandong Xinhua Pharmaceutical Company Limited's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of September 2023, the index stands at 84.9%, representing strategic assets of €3.99 Billion against net assets of €4.70 Billion EUR. Explore XIN operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Shandong Xinhua Pharmaceutical Company Limited (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see XIN company net worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 92.0% | €4.00 Billion | €4.00 Billion | €- | €4.35 Billion | ▼ -11.2 pp |
| 2021 | 103.1% | €3.77 Billion | €3.77 Billion | €- | €3.65 Billion | ▼ -1.2 pp |
| 2020 | 104.4% | €3.54 Billion | €3.54 Billion | €- | €3.39 Billion | ▼ -8.1 pp |
| 2019 | 112.4% | €3.50 Billion | €3.20 Billion | €296.25 Million | €3.11 Billion | ▲ +1.9 pp |
| 2018 | 110.6% | €3.09 Billion | €2.90 Billion | €189.74 Million | €2.80 Billion | ▲ +0.2 pp |
| 2017 | 110.3% | €2.85 Billion | €2.59 Billion | €258.14 Million | €2.58 Billion | ▼ -14.0 pp |
| 2016 | 124.3% | €2.58 Billion | €2.40 Billion | €189.47 Million | €2.08 Billion | ▲ +2.0 pp |
| 2015 | 122.3% | €2.43 Billion | €2.23 Billion | €200.43 Million | €1.98 Billion | ▼ -1.9 pp |
| 2014 | 124.2% | €2.37 Billion | €2.15 Billion | €220.59 Million | €1.91 Billion | ▲ +11.6 pp |
| 2013 | 112.5% | €2.12 Billion | €1.99 Billion | €127.41 Million | €1.88 Billion | — |